Top Story

PUBLICATION EXCLUSIVE: Presbyopia treatment in 2017: Where are we?

PUBLICATION EXCLUSIVE: Presbyopia treatment in 2017: Where are we?
April 30, 2017

In this edition of Ocular Surgery News, the OSN Roundtable discusses how presbyopia is becoming a subspecialty of  ophthalmology. In this guest commentary, Francesco Carones, MD, weighs in on the topic

Looking at the present state of refractive surgery, in which the correction of refractive errors such as myopia, hyperopia and astigmatism has become safe, accurate and precise with outstanding results for most patients, I feel that presbyopia correction still involves challenges and compromises. Think of the procedures we use to correct, let’s say, 2 D of myopia. I can count three, maybe four, surgical techniques that are currently used — LASIK, PRK, advanced surface ablation, SMILE — and all of them provide similar, excellent results. Think now of the procedures we use to correct the same amount of presbyopia, 2 D. I can count at least 10 different approaches, and none of them gives the same results. This, however, does not mean that presbyopia cannot be safely and successfully corrected. It means that each single approach has potential advantages but also downsides leading to compromises, and our challenge as surgeons is to identify for each single patient what is the best acceptable combination between advantages and compromises.

Mayo Clinic's 'medical school of the future' tops April news

April 29, 2017
April brought FDA approvals and the passing of one of the ophthalmology world’s most distinguished figures, but the AMA’s announcement that it was working…

Barrett Suite integrated into Zeiss’ IOLMaster 700

April 28, 2017
The Barrett Suite, which includes three new IOL power calculation formulas, has been fully integrated into the IOLMaster 700 for more accurate prediction of refractive…

Nicox reports first quarter highlights

April 28, 2017
Nicox reported it had cash, cash equivalents and financial instruments totaling 25 million as of March 31 compared with 28.9 million as of Dec. 31, 2016, according to a…

Alcon introduces two vitreoretinal surgical technologies

April 28, 2017
Alcon is launching two vitreoretinal surgical products at the FLOREtina Retina Meeting in Florence, Italy, according to a press release. The Advanced Ultravit beveled…
More News Headlines »
Clinical ScienceOpen Access

Use of Corticosteroids in the Treatment of Patients With Diabetic Macular Edema Who Have a Suboptimal Response to Anti-VEGF: Recommendations of an Expert Panel

Ophthalmic Surgery, Lasers and Imaging Retina, April 2017, Volume 48 Issue 4
Guidance on the use of corticosteroids in the treatment of diabetic macular edema (DME) is lacking. This study aimed to…
More »

Best of Retina Forum® 2016 - Diabetic Retinopathy: A Revolution in Treatment Options

This activity is supported by educational grants from Carl Zeiss Meditec, Inc. and Regeneron Pharmaceuticals, Inc.

Diabetic retinopathy (DR) is an insidious, progressive disease. Diabetic macular edema (DME), which can occur at any…
More »
From OSN Europe Video
Meeting News

VIDEO: Surgeon speaks about the advantages of CAPSULaser in cataract surgery

February 23, 2017
More »